Search Ontology:
ChEBI
1-palmitoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphate
- Term ID
- CHEBI:83785
- Synonyms
-
- (2R)-1-(hexadecanoyloxy)-3-(phosphonooxy)propan-2-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
- 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphate
- 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphate
- PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
- PA(16:0/22:6)
- Definition
- A 1,2-diacyl-sn-glycerol 3-phosphate in which the 1- and 2-acyl substituent are specified as palmitoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.
- References
-
- LIPID_MAPS_instance:LMGP10010038
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
- inverse is_conjugate_base_of
-
- is_conjugate_acid_of
-
Phenotype
Phenotype resulting from 1-palmitoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphate
Phenotype where environments contain 1-palmitoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphate
Phenotype modified by environments containing 1-palmitoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphate
Human Disease Model